Browsing Tag

Technology

2424 posts
Read More

SullivanStrickler and Bluesource Announce Alliance

Bluesource and SullivanStrickler LLC today announced a strategic alliance designed to help clients with data governance, compliance and eDiscovery needs around Microsoft Office 365 and Advanced eDiscovery. With support of Microsoft, Bluesource's data governance solutions and SullivanStrickler's legacy data management services will provide an end-to-end approach to corporate Microsoft Office 365 environments and will include support of legal counsel from a global law firm. Leveraging over 30 years of combined world-class experience in data remediation, migration, discovery and technology-related services, clients will benefit from a holistic approach around consulting, development and implementation of data solutions.

Read More

InComm and LA Metro Partner to Expand Access to TAP Card Sales Throughout LA County

InComm, a leading payments technology company, announced today that it is partnering with the Los Angeles County Metropolitan Transportation Authority (Metro) to expand the network of retail locations at which customers can purchase and reload TAP cards. TAP riders can currently buy and reload TAP cards at more than 450 retail locations across Los Angeles County; this partnership will expand that total to more than 2,000 stores in 2020.

Read More

Cryptocurrency ATM Network Bitcoin Depot Acquires Texas-Based Competitor, DFW Bitcoin in First-of-its-Kind Acquisition

Bitcoin Depot, a cryptocurrency ATM network based in Atlanta, Georgia, today announced the acquisition of competitor, DFW Bitcoin. This acquisition is the first of its kind between Bitcoin ATM operators, and signals continued strong growth in the industry, in line with expert projections forecasting an annual compound growth rate of 46.61 percent by 2024(1).

Emil Kakkis Joins Nonprofit Biotech Odylia Therapeutics Board of Directors

Emil Kakkis, MD, PhD, joins the Board of Directors of Odylia Therapeutics. Kakkis is the CEO, President and Founder of Ultragenyx Pharmaceutical Inc., which is committed to developing and commercializing treatments for rare and ultra-rare diseases. He brings to Odylia knowledge of the needs and opportunities in developing life-altering therapies for rare diseases. Dr. Kakkis states "Odylia is a unique organization with the potential to truly shift the way therapies are brought to market, ultimately bringing life changing treatments to people living with rare diseases. I'm looking forward to being part of their work."